This inventor holds 3 USPTO granted patents. Top assignee: The Board of Regents of the University of Nebraska. Active years: 2016-2021.
Company Filing History:
Years Active: 2016-2021
Title: Joseph A Vetro: Innovator in Controlled-Release Peptide Compositions
Introduction
Joseph A Vetro is a notable inventor based in Logan, IA (US). He has made significant contributions to the field of peptide compositions, particularly in the development of controlled-release formulations. With a total of three patents to his name, Vetro's work is focused on innovative solutions for treating infections and diseases.
Latest Patents
Vetro's latest patents include advancements in controlled-release peptide compositions. These formulations involve carboxy-terminal C5a analogs, which are designed for sustained-release applications. His work aims to provide methods for treating and preventing infections or diseases such as cancer. Additionally, these formulations are intended for directly killing microorganisms, preparing vaccines, inducing immune responses, and targeting antigen-presenting cells and other cells that bear a C5a receptor.
Career Highlights
Joseph A Vetro is affiliated with the University of Nebraska, where he continues to advance his research in peptide compositions. His innovative work has garnered attention in the scientific community, contributing to the understanding and treatment of various diseases.
Collaborations
Vetro collaborates with Sam D Sanderson, enhancing the research and development of his patented technologies. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
Joseph A Vetro's contributions to controlled-release peptide compositions represent a significant advancement in medical science. His patents reflect a commitment to improving treatment methods for serious health conditions.